Ignite Creation Date:
2024-05-06 @ 2:28 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04322149
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2020-03-20
Brief Title:
Multiple Doses of AT-1501-A201 in Adults With ALS
Sponsor:
Anelixis Therapeutics LLC
Organization:
Eledon Pharmaceuticals
Organization Data
Organization:
Eledon Pharmaceuticals
Class:
INDUSTRY
Study ID:
AT-1501-A201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Anelixis Therapeutics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None